Alliancebernstein L.P. Frequency Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $34,814 - $68,614	-33,800 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $5,610 - $18,876	-3,300 Reduced 8.89%	33,800 $72,000
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $12,375 - $17,775	-2,500 Reduced 6.31%	37,100 $190,000
Q2 2021 Jul 30, 2021	BUY	$8.05 - $11.61 $38,640 - $55,728	4,800 Added 13.79%	39,600 $394,000
Q1 2021 May 06, 2021	BUY	$7.99 - $55.01 $30,362 - $209,038	3,800 Added 12.26%	34,800 $331,000
Q4 2020 Feb 08, 2021	SELL	$18.65 - $40.0 $41,030 - $88,000	-2,200 Reduced 6.63%	31,000 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$17.76 - $24.96 $23,088 - $32,448	-1,300 Reduced 3.77%	33,200 $638,000
Q2 2020 Aug 13, 2020	BUY	$14.65 - $24.9 $505,425 - $859,050	34,500 New	34,500 $802,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.